Upgrade to SI Premium - Free Trial

Audentes Therapeutics (BOLD) Tops Q2 EPS by 3c

August 6, 2019 4:53 PM
Audentes Therapeutics (NASDAQ: BOLD) reported Q2 EPS of ($1.01), $0.03 better than the analyst estimate of ($1.04)."It is a very ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings

Next Articles